Equatorial Guinea vs Lithuania: The number of people with susceptibility test result for rifampicin
Equatorial Guinea
492
in 2021
Lithuania
465
in 2021
Equatorial Guinea rank
80th
Lithuania rank
82nd
The number of people with susceptibility test result for rifampicin over time
- Equatorial Guinea
- Lithuania
How they compare
Equatorial Guinea currently reports 492 against 465 in Lithuania, a difference of 27.
That makes Equatorial Guinea's figure about 1.1 times Lithuania's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Lithuania ahead.
Equatorial Guinea ranks 80th and Lithuania ranks 82nd of 155 countries.
Lithuania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Equatorial Guinea | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 31.33 | 777 | 745.67 | Lithuania |
| 2020s | 371 | 474 | 103 | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Equatorial Guinea or Lithuania?
- Equatorial Guinea, at 492 against 465 in Lithuania as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Equatorial Guinea and Lithuania?
- 27, with Equatorial Guinea ahead.
- How many years of comparable data are there for Equatorial Guinea and Lithuania?
- 5 years are reported by both, from 2017 to 2021.
- How do Equatorial Guinea and Lithuania rank globally for the number of people with susceptibility test result for rifampicin?
- Equatorial Guinea ranks 80th and Lithuania ranks 82nd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.